 |
|
|
| |
No Clinically Significant Interaction of the Proton Pump
Inhibitor Omeprazole With the Components of MK-3682B
|
| |
| |
Reported by Jules Levin18th
18th International Workshop on Clinical Pharmacology of Antiviral Therapy; Chicago, IL, USA; 14-16 June 2017.
Leticia Arrington1*; Wei Gao1; Xiaoli Shirley Glasgow1; Julie Luk1; Deborah Panebianco1; Matthew L. Rizk1; Yuting Zhou2; John Brejda2; Laura Sterling2; Marian Iwamoto1; and Nancy Kim1
*Corresponding author1Merck & Co., Inc., Kenilworth, NJ, USA2Celerion, Inc., Lincoln, NE, USA
|
| |
|
|
|
|
|
